Schedule

Metronomic Scheduling The Next Generation of Multi-Target Therapy

Day -1: Workshop on Clinical Trial Designing & Translational Research for Metronomic Studies

Sandra Doe

Dr Arun C, Dr Mounika, Dr Anant R, Dr Ashay Karpe, Dr Bhavesh Poladia, Dr Deepan M.

Sandra Doe

Dr. B K Smruti, Mumbai; Dr. Manoj Mahimkar, Mumbai; Dr Rita Mulherkar, Mumbai.

John Doe

WHY METRONOMICS?

Pharmacokinetics of low doses : Dr. Vikram Gota, Mumbai

Repositioning of drugs in oncology : The ReDo Project: Dr. Pan Pantziarka, Belgium

Key note lecture : Next - generation drug repositioning : using high-throughput screening technology to improve cancer treatment : Dr. Eddy Pasquier, France

John Doe

Question and answer session

Tea Break

Michael Doe

Dr. Asha Kapadia - Mumbai, Dr. Nicolas Andre - France, Dr. Rakesh Jalali - Mumbai

John Doe

DESIGN OF METRONOMIC STUDIES:

Single Arm studies in metronomic therapy : Dr. Aparna Parikh, Mumbai

Randomized Phase 2 studies in metronomic therapy : Dr. Sudeep Gupta, Mumbai

Randomized Phase 3 studies in metronomic therapy: Dr. Kumar Prabhash, Mumbai

Response assement in metronomic therapy
Radiologist View: Dr. Abhishek Mahajan, Mumbai
Nuclear Medicine view : Dr Nilendu Purandare, Mumbai

LUNCH

John Doe

Dr Lisa Hutchinson - UK, Dr Urmila Thatte - Mumbai, Dr. Robert Kerbel - Canada.

John Doe

ENDPOINT SELECTION IN METRONOMIC TRIALS:

Appropriate clinical end point selection for metronomic studies : Dr. Atanu Bhattacharjee - Thalassary

Selection of Translational end points for metronomic studies : Dr. Shona Nag - Pune

Tumor Immunity related marker selection and methodologies for metronomic studies: Dr. Shubhada Chiplunkar, Navi Mumbai

Efficacy V/s. Toxicity endpoint selection for metronomic studies : Dr. Sadhana K - Navi Mumbai

John Doe

Question and answer session

Michael Doe

Dr. SH Advani - Mumbai, Dr. Pratamesh Pai - Mumbai, Dr. Amol Dongre - Nagpur

John Doe

MATHEMATICS & BIOLOGY IN METRONONIC THERAPIES:

Mathematical Modelling of Chemotherapy Scheduling: Dr. Sébastien Benzekry - France

Systematic analysis of host and tumor effects to metronomic chemotherapy regimen : Dr. Yuval Shaked, Israel

John Doe

Question and answer session

Tea Break

Michael Doe

Dr. Jayant Gawande - Pune; Dr. Pankaj Shah - Ahmadabad; Dr.Prashant - Chennai.

John Doe

Debate: Tumor shrinkage (objective response) or clinical benefit rate : Which is the appropriate efficacy endpoint for metronomic therapy?

For Tumor shrinkage : Dr Amish Vora, Delhi (10 min)
For Clinical benefit rate : Dr Randeep Singh, Delhi (10 min)
Retrieval 5 min each

John Doe

Panel Discussion: Survey of practice, perception and promise in metronomic therapy and generation of a consensus statement

Moderators: Dr Purvish Parikh, Mumbai & Dr Vanita Noronha, Mumbai

Panelists: Dr GS Bhattacharyya, Kolkatta; Dr Sudeep Gupta, Mumbai; Dr Kumar Prabhash, Mumbai; Dr Satheesan B, Thallasery; Dr Raman Govindarajan, Mumbai; Dr Partha Roy, Gauhati; Dr Nishita Shetty, Mangalore; Dr Gautam Goyal , Mumbai ; Dr Hari Menon, Mumbai; Dr Avinash Pandey, Hyderabad; Dr Padmaj Kulkarni, Pune; Dr Bharat Bhosale, Mumbai; Dr Amit Dutt, Mumbai.

Partners and Sponsors

Contact

  • R.R. Choksi Auditorium,
    Tata Memorial Hospital,
    Parel, Mumbai. India.
  • event@metronomicsmumbai.com
  • Dr. Shripad Banavali - 9820074514
  • Dr. Vijay Patil - 9869382266
  • Ms. Leena Walvankar - 9773862355

Copyrights © Metronomics Mumbai 2016 | Complete Web & IT Solutions by NWDCo